29 min listen
The Underlying Biology of Drug Resistance with Dr. Sarat Chandarlapaty
The Underlying Biology of Drug Resistance with Dr. Sarat Chandarlapaty
ratings:
Length:
34 minutes
Released:
May 28, 2020
Format:
Podcast episode
Description
Advances in cancer therapy have dramatically contributed to the decline in breast cancer deaths over the last three decades. But even with these advances, drug resistance—when tumors stop responding to anti-cancer drugs—remains a serious clinical challenge. Dr. Sarat Chandarlapaty talks about the strategies to prevent cancer cells from evading the drugs designed to kill them.
Dr. Chandarlapaty is a laboratory head at the Human Oncology and Pathogenesis Program at the Memorial Sloan Kettering Cancer Center. He's also a BCRF Scientific Advisory Board member and has been a BCRF researcher since 2015.
Dr. Chandarlapaty is a laboratory head at the Human Oncology and Pathogenesis Program at the Memorial Sloan Kettering Cancer Center. He's also a BCRF Scientific Advisory Board member and has been a BCRF researcher since 2015.
Released:
May 28, 2020
Format:
Podcast episode
Titles in the series (46)
Mapping and understanding brain metastasis in breast cancer, with Dr. Priscilla Brastianos: Metastasis, when cancer cells leave the breast and spread to other sites in the body, is the major cause of mortality from breast cancer. The brain is one of the most common organs breast cancer invades, occurring in more than one third of patients with ... by Investigating Breast Cancer